CRF Connect Logo
  • Tracks & Learning Series
    VIEW ALL
  • Conferences
  • My Favorites

Coronary

Techniques and Lesion Subsets Learning Series

Pharmacotherapy

Coronary >
Pharmacotherapy

Episodes

For Most Patients, Only Spontaneous MI Is Relevant

For Most Patients, Only Spontaneous MI Is Relevant

6 min.

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

Novel Approaches to Reduce and Reverse Bleeding in Complex PCI

8 min.

The Importance of Addressing Lipids in Patients With Complex PCI

The Importance of Addressing Lipids in Patients With Complex PCI

8 min.

Periprocedural MI Matters to All Patients!

Periprocedural MI Matters to All Patients!

4 min.

Does It Matter What Stent I Use in a HBR Patient?

Does It Matter What Stent I Use in a HBR Patient?

8 min.

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

New and Emerging Pharmacology for ACS: Lipid Modulation and Anti-Inflammatory Agents

8 min.

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

My Roadmap for Preprocedure and Intraprocedural Antithrombotic Therapy in Complex PCI

8 min.

New and Emerging Pharmacology for ACS: Factor XI Inhibition

New and Emerging Pharmacology for ACS: Factor XI Inhibition

6 min.

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

PCI in Patients With AF: The Risk and Benefit of Antithrombotic Therapy

7 min.

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

P2Y12 Inhibitors in ACS: Which Agent in Which Patient and When?

7 min.

Short DAPT or De-Escalation After ACS

Short DAPT or De-Escalation After ACS

7 min.

Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?

Does Bleeding Risk Outweigh Thrombotic Risk or Vice Versa?

8 min.

This website uses cookies to ensure you get the best experience on our website. Read More